Dr. Li Huai

CancerFax can coordinate medical-record review and consultation support for international patients seeking an opinion from Prof. Li Huai at Humanity Hospital Xiamen, subject to hospital availability and case acceptance.

Prof. Li Huai specialises in interventional oncology, with a particular focus on hepatocellular carcinoma (HCC), liver metastases, and pancreatic cancer. He also has broad experience managing diverse complex and refractory malignancies through vascular interventional approaches.

Interventional oncology uses minimally invasive image-guided procedures — such as transarterial chemoembolisation (TACE) and arterial infusion techniques — to deliver treatment directly to tumours. These approaches are particularly valuable for patients with liver or pancreatic cancers who are not suitable candidates for surgery or who require treatment alongside systemic therapy.

Submit your medical reports through CancerFax. The CancerFax team will review the documents, prepare the case for submission, and coordinate the next steps with Humanity Hospital Xiamen, subject to availability and case eligibility.

A second-opinion request can be submitted through CancerFax with the patient's pathology reports, imaging, treatment history, and relevant test results. The final consultation format and availability depend on Prof. Li's schedule at Humanity Hospital Xiamen.

Prof. Li Huai holds senior national roles including Honorary Chairperson of the Chinese Research Hospital Association, Consultation Expert to the Central Health Commission, Executive Committee Member of the Clinical Oncology Cooperation Committee of the Chinese Anti-Cancer Association, and Standing Committee Member of the Tumour Intervention Committee of the Chinese Anti-Cancer Association.